Results 231 to 240 of about 119,290 (297)

Development and Characterization of Microsatellite Genetic Markers for <i>Hyalomma rufipes</i>, a Tick Vector of Crimean-Congo Hemorrhagic Fever Virus. [PDF]

Ecol Evol
Ahmad H, Aool W, Anyango V, Nakayaki TM, Mulwa F, Chelangat B, Lutwama JJ, Kayondo JK, Lukindu M, Mutisya J, Lutomiah J, Hensley LE, Cohnstaedt LW, Onyango MG, Brelsfoard CL.   +14 more
europepmc   +1 more source

Infectious Disease Response in Tanzania: Enhanced Strategies From the 2023 to 2025 Marburg Outbreaks

Public Health Challenges, Volume 5, Issue 2, June 2026.
ABSTRACT The 2023 Marburg virus disease (MVD) outbreak in Tanzania, which resulted in nine confirmed cases and six deaths (case fatality rate [CFR]: 66.7%), served as a critical stress test of the national health system, revealing significant gaps in outbreak preparedness across surveillance, laboratory capacity, and infection prevention and control ...
Huda Haque, Faraan O. Rahim, Sameer Abbasi, Nam Nguyen, Erick Mahatara, Alison Jang, Ntuli A. Kapologwe   +6 more
wiley   +1 more source

Crimean-Congo hemorrhagic fever virus localization and shedding in the reproductive tract of lethal and survivor mouse models. [PDF]

Emerg Microbes Infect
Sorvillo TE, Ritter JM, Welch SR, Davies KA, Coleman-McCray JD, Hayes HM, Ficarra G, Bhatnagar J, Pegan SD, Bergeron É, Montgomery JM, Spiropoulou CF, Spengler JR.   +12 more
europepmc   +1 more source

Cost‐Effectiveness of Venetoclax‐Based Treatment in Treatment‐Naïve Fit Patients With CLL Without TP53 Aberrations

European Journal of Haematology, Volume 116, Issue 6, Page 873-882, June 2026.
ABSTRACT The GAIA‐CLL13 trial showed that venetoclax‐obinutuzumab (Ven‐O) based regimens, with or without ibrutinib, offer superior efficacy compared to chemoimmunotherapy (CIT) with regards to progression free survival (PFS) in fit, treatment‐naïve (TN) CLL patients. However, their higher costs warrant a cost‐effectiveness evaluation.
Lars Holger Ehlers, Mark‐David Levin, Marjolein van der Klift, Morten Berg Jensen, Hoa Thi Tuyet Tran, Arnon P. Kater, Carsten Utoft Niemann   +6 more
wiley   +1 more source

In Vitro and In Vivo Models for Drug Development Against Two Hemorrhagic <i>Hareavirales</i>: Rift Valley Fever and Crimean Congo Hemorrhagic Fever Viruses. [PDF]

Viruses
Chaput S, Nougairède A, Touret F.
europepmc   +1 more source

Risk Factors for Tick‐Borne Diseases in Germany: A Scoping Review

Zoonoses and Public Health, Volume 73, Issue 4, Page 297-313, June 2026.
ABSTRACT Tick‐borne diseases (TBDs) have proliferated in Germany. The two most prevalent TBDs, Lyme‐borreliosis and tick‐borne encephalitis, can present with nonspecific symptoms and lead to serious neurological complications. To date, a review synthesising the risk factors of acquiring a TBD in Germany is missing.
Carolin Schlupp, Matthias Hans Belau
wiley   +1 more source

Seroprevalence of Rift Valley and Crimean-Congo Hemorrhagic Fever Viruses, Benin, 2022-2023. [PDF]

Emerg Infect Dis
Olk N, Yadouleton A, Quenum O, Sohou S, Goundote A, Rodrigue GAG, Guezo-Mevo B, Bedie S, Nagel M, Emmerich P, Hounkpatin B, Drexler JF.   +11 more
europepmc   +1 more source

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia

American Journal of Hematology, Volume 101, Issue 5, Page 1019-1024, May 2026.
ABSTRACT Preclinical studies showed a synergistic antileukemia activity with combination of selective XPO1 inhibitor selinexor (SEL) and venetoclax (VEN), with potential to overcome VEN resistance by reducing the anti‐apoptotic protein MCL1. In an investigator‐sponsored, open‐label, phase Ib study (NCT03955783), adult patients with relapsed or ...
Somedeb Ball, Farrukh T. Awan, Ben K. Tomlinson, Tess Stopczynski, Melissa A. Fischer, Zhiguo Zhao, Kateryna Fedorov, Ashwin Kishtagari, Sanjay R. Mohan, Gregory D. Ayers, Michael T. Byrne, Michael R. Savona   +11 more
wiley   +1 more source

Crimean-Congo Hemorrhagic Fever Virus among Goats, Southern Bhutan. [PDF]

Emerg Infect Dis
Rinchen S, Kaku Y, Park E, Sharma PM, Tshering D, Tenzin T, Matsuu A, Okutani A, Maeda K, Morikawa S.   +9 more
europepmc   +1 more source

Risk Factors for 30-Day Prognosis of Hemorrhagic Fever with Renal Syndrome in the Dali Region, China. [PDF]

Infect Drug Resist
Huang L, Yan Q, Gao XM, Gu W.
europepmc   +1 more source